NeOnc Technologies Holdings, Inc. (NTHI)
3.19
-0.01
(-0.31%)
USD |
NASDAQ |
Nov 06, 10:29
NeOnc Technologies Holdings Debt to Equity Ratio : -0.0177 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0177 |
| March 31, 2026 | -0.0262 |
| December 31, 2025 | -0.3606 |
| September 30, 2025 | -0.4299 |
| June 30, 2025 | -0.0335 |
| March 31, 2025 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2024 | -0.0045 |
| September 30, 2024 | -0.0707 |
| March 31, 2024 | |
| December 31, 2023 | -0.4722 |
| September 30, 2023 | -0.4056 |
| December 31, 2022 | -0.0317 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Cocrystal Pharma, Inc. | 1.284 |
| CNBX Pharmaceuticals, Inc. | -0.4388 |
| Arvinas, Inc. | 0.0148 |
| Fulcrum Therapeutics, Inc. | 0.017 |
| Definium Therapeutics, Inc. | 0.0397 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 5.232M |
| Total Liabilities (Quarterly) | 23.76M |
| Shareholders Equity (Quarterly) | -18.53M |
| Current Ratio | 0.1438 |
| Net Debt Paydown Yield | -0.06% |